These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8573301)

  • 1. Malaria vaccine trials: SPf66 and all that.
    Riley E
    Curr Opin Immunol; 1995 Oct; 7(5):612-6. PubMed ID: 8573301
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
    Nosten F; Luxemburger C; Kyle DE; Ballou WR; Wittes J; Wah E; Chongsuphajaisiddhi T; Gordon DM; White NJ; Sadoff JC; Heppner DG
    Lancet; 1996 Sep; 348(9029):701-7. PubMed ID: 8806288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
    Haywood M; Conway DJ; Weiss H; Metzger W; D'Alessandro U; Snounou G; Targett G; Greenwood B
    Trans R Soc Trop Med Hyg; 1999 Feb; 93 Suppl 1():65-8. PubMed ID: 10450429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
    Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.
    Schellenberg DM; Acosta CJ; Galindo CM; Kahigwa E; Urassa H; Masanja H; Aponte JJ; Schellenberg JR; Fraser-Hurt N; Lwilla F; Menendez C; Mshinda H; Tanner M; Alonso PL
    Trop Med Int Health; 1999 May; 4(5):377-82. PubMed ID: 10402974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66.
    Bojang KA; Obaro SK; Leach A; D'Alessandro U; Bennett S; Metzger W; Ballou WR; Targett GA; Greenwood BM
    Parasite Immunol; 1997 Dec; 19(12):579-81. PubMed ID: 9458470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children.
    Trape JF; Rogier C
    Lancet; 1995 Jan; 345(8942):134-5. PubMed ID: 7815878
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2000; (2):CD000129. PubMed ID: 10796492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines: a roller-coaster of hopes.
    Butler D; Maurice J; O'Brien C
    Nature; 1997 Apr; 386(6625):537-8. PubMed ID: 9121568
    [No Abstract]   [Full Text] [Related]  

  • 10. Malaria: a protective paradox.
    Hoffman SL
    Nature; 2006 Dec; 444(7121):824-7. PubMed ID: 17151601
    [No Abstract]   [Full Text] [Related]  

  • 11. The vaccine is dead--long live the vaccine.
    Snounou G; Rénia L
    Trends Parasitol; 2007 Apr; 23(4):129-32. PubMed ID: 17300988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria vaccine trials: the missing qualitative data.
    Ferreira M
    Immunol Cell Biol; 1996 Aug; 74(4):301-5. PubMed ID: 8872178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
    Rosas JE; Pedraz JL; Hernández RM; Gascón AR; Igartua M; Guzmán F; Rodríguez R; Cortés J; Patarroyo ME
    Vaccine; 2002 Mar; 20(13-14):1707-10. PubMed ID: 11906756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
    Alonzo PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos De Azevedo I; Chongela J; Kobero S; Menendez C
    Med Trop (Mars); 1995; 55(4 Suppl):41-6. PubMed ID: 8649265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
    Alonso PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos de Azevedo I; Chongela J; Kobero S; Menendez C
    Lancet; 1994 Oct; 344(8931):1175-81. PubMed ID: 7934537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
    Noya O; Gabaldón Berti Y; Alarcón de Noya B; Borges R; Zerpa N; Urbáez JD; Madonna A; Garrido E; Jimenéz MA; Borges RE
    J Infect Dis; 1994 Aug; 170(2):396-402. PubMed ID: 8035026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.
    Rosas JE; Hernández RM; Gascón AR; Igartua M; Guzman F; Patarroyo ME; Pedraz JL
    Vaccine; 2001 Aug; 19(31):4445-51. PubMed ID: 11483270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
    Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
    Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria vaccine.
    Trager W
    Science; 1995 Mar; 267(5204):1577. PubMed ID: 7886435
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.
    Pöltl-Frank F; Zurbriggen R; Helg A; Stuart F; Robinson J; Glück R; Pluschke G
    Clin Exp Immunol; 1999 Sep; 117(3):496-503. PubMed ID: 10469053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.